Overview
Utilizing a data-driven approach during candidate selection is key when trying to achieve proof-of-concept success. By applying key strategies during the preclinical stage, such as salt and polymorph screening and prototype selection, you are able to gain a complete understanding of the characteristics of your API which will help determine your target product profile and dosage form selection. Getting a clear picture early on of the safety and efficacy of your drug product will help your program advance effectively and efficiently into first-in-human and then quickly transition through to proof-of-concept and beyond.
Agenda
The seminar starts at 11:00 am on Thursday, May 30, 2019 and finishes at 1:00 pm on the same day.
11:00am - 11:30am - Registration & Lunch
11:30am - 12:30pm - Seminar
12:30pm - 1:00pm - Q&A and Networking